Gamida Cell Ltd.

NAS: GMDA

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 29, 2022, 1:58 p.m.

/zigman2/quotes/207657083/composite

$

1.74

Change

+0.12 +7.10%

Volume

Volume 1.01m

Real time quotes

/zigman2/quotes/207657083/composite

Previous close

$ 1.62

$ 1.74

Change

+0.12 +7.10%

Day low

Day high

$1.60

$1.79

Open

52 week low

52 week high

$1.47

$4.72

Open

Michele I. Korfin

Michele I. Korfin is Chief Operating & Commercial Officer at Gamida Cell Ltd. and Secretary & Trustee at BioNJ, Inc. He is also on the board of Organogenesis Holdings, Inc.

In the past Mr. Korfin was Chief Operating Officer for Tyme Technologies, Inc., Head-Oncology Sales Force at Celgene Corp. and Vice President-Market Access at Kite Pharma, Inc.

Mr. Korfin received an MBA from Harvard Business School and an undergraduate degree from Rutgers State University of New Jersey.

Transactions

Date Shares Transaction Value
01/28/2022 63,800   Award at $0 per share. 0

Officers and Executives

Mr. Robert I. Blum
Chairman
Dr. Julian Adams
Chief Executive Officer & Director
Mr. Michele I. Korfin
Chief Operating & Commercial Officer
Mr. Shai Lankry
Chief Financial Officer
Dr. Yona Geffen
Vice President-Research & Development
Dr. Ronit Simantov
Chief Medical & Scientific Officer
Mr. Vladimir Melnikov
Senior VP-Global Operations & Manufacturing
Mr. Joshua F. Patterson
Chief Compliance Officer & General Counsel
Mr. Tzvi Palash
Chief Manufacturing Officer
Dr. Anat Cohen-Dayag
Director
Dr. Naama Halevi-Davidov
Director
Dr. Ivan M. Borrello
Director
Mr. Yisrael Gewirtz
Internal Auditor
Ms. Heather DiVecchia
Chief of Staff
Dr. Jas Uppal
Chief Regulatory & Quality Officer
Ms. Shawn Cline Tomasello
Independent Director
Mr. Stephen T. Wills
Independent Director
Mr. Kenneth I. Moch
Independent Non-Executive Director
Link to MarketWatch's Slice.